학술논문

TP53 mutations as predictor of response and longer survival under immune checkpoint inhibitors in advanced non-small cell lung cancer
Document Type
Article
Source
In: Annals of oncology : official journal of the European Society for Medical Oncology. (Annals of oncology : official journal of the European Society for Medical Oncology, 1 September 2018, 29:vi19)
Subject
Language
English
ISSN
15698041